All Infection Prevention & Control articles – Page 70
-
NewsResearchers in Brazil discover a gene that may afford protection against COVID-19
During the pandemic, health worker Maria Tereza Malheiros Sapienza’s curiosity was aroused by her immunity to SARS-CoV-2, even though her husband was infected twice. A new study reveals that an overexpression of IFIT3 protein was responsible.
-
NewsWeather change linked to increased risk of Salmonella outbreaks
A research study has shown a significant impact on Salmonella outbreaks from weather changes, which can be used as a tool to predict risk of outbreaks and implement preventative measures, under a climate change scenario.
-
NewsWHO verifies Niger as the first country in the African Region to eliminate onchocerciasis
Niger has met the criteria for onchocerciasis elimination, making it the fifth country globally and the first country in Africa to be acknowledged by WHO for interrupting transmission of the parasite Onchocerca volvulus.
-
NewsGuinea eliminates human African trypanosomiasis as a public health problem
The World Health Organization (WHO) has congratulated Guinea for eliminating the gambiense form of human African trypanosomiasis as a public health problem. This is the first neglected tropical disease to be eliminated in the country.
-
NewsPapers outline 4 advances for inactivating infectious viruses and bacteria
Four papers provide insights into novel antiviral compounds and methods to inactivate infectious viral particles and bacteria.
-
NewsJapan’s ‘soft’ but not ineffective approach to public health during the COVID-19 pandemic
Researchers found that risk perception and infection prevention behaviors rose during Japan’s COVID-19 state of emergency. After it was lifted, hygienic behaviors persisted, but dread risk perception declined.
-
NewsStudy finds three new safe, effective ways to treat drug-resistant tuberculosis
An international clinical trial has found three new safe and effective drug regimens for tuberculosis that is resistant to rifampin, the most effective of the first-line antibiotics used to treat TB.
-
NewsTB or not TB? A new clinician decision support tool for tuberculosis
A risk assessing tool was recently developed to evaluate the likelihood of tuberculosis (TB) infections using previous patient data with or without TB. Such clinical decision support tool would allow safer and more efficient patient deisolation procedures and ensure smoother clinician workflows.
-
NewsMost Americans favor school vaccination requirements, but support is rising for opt-out options
A new survey finds that nearly three-quarters of U.S. adults support requiring that children be vaccinated against preventable diseases such as measles, mumps, and rubella.
-
NewsInternational disease classification codes ambiguities create challenges in comparing respiratory infection diagnose
The International Classification of Diseases (ICD) system standardizes diagnostic codes globally, enabling accurate comparisons of health data. This study investigated regional differences in respiratory infection diagnoses to identify potential ambiguities in ICD coding and their implications for data comparability.
-
OpinionReproductive biology though the lens of the microbiome
Madangchanok Imchen and Seth R. Bordenstein from the One Health Microbiome Center - winner of AMI’s WH Pierce Prize 2024 - explore the potential of the reproductive microbiome, particularly the fascinating Wolbachia, to counter global disease threats.
-
NewsA new vaccine approach could help combat future coronavirus pandemics
Researchers are able to create a mosaic nanoparticle vaccine - mosaic-8, based on the sarbecovirus receptor-binding proteins (RBDs), which would help combatting SARS-CoV-2 variants and other coronavirus subtypes.
-
NewsViruses and the human cell: The evolutionary arms race
Researchers have discovered a unique genetic mechanism that provides cells with rapid and efficient protection against viruses. The findings could lead to the development of new therapeutics.
-
NewsV-161: A breakthrough in the fight against antibiotic-resistant VRE infections
Researchers from Japan have identified V-161, a compound that inhibits Enterococcus hirae V-ATPase activity, disrupting Na+ transport and effectively inhibiting VRE growth.
-
NewsUltrasensitive test detects, serially monitors intact virus levels in patients with COVID-19
A highly sensitive approach, adapted from cancer vesicles detection, was discovered to be able to detect SARS-CoV-2 viral particles in fluid samples of patients with acute COVID-19 infections.
-
NewsAntiviral protein causes genetic changes implicated in Huntington’s disease progression
A new study shows APOBEC enzymes, which normally help fight viral infections by mutating viral DNA, are unusually active in the brains of Huntington’s patients.
-
NewsUnderestimated risk: Germs in the kitchen
In the most recent BfR consumer monitor, only 17 per cent of respondents said they were concerned about kitchen hygiene. The level of concern about microplastics (68 per cent) and residues of plant protection products in food (52 per cent) is significantly higher.
-
NewsNew paper creates roadmap for the next generation of bioelectronic medicine
A new paper offers a roadmap to the future of bioelectronic medicine — which makes use of electrical signals instead of drugs to diagnose and treat disease.
-
NewsTowards improved pandemic preparedness: Launch of new EU project COMBINE
A project for the targeted development of antiviral therapies for newly emerging viruses, COMBINE focuses on the critical virus-cell binding step, aiming to identify key factors and potential therapeutic targets involved early in viral infections.
-
NewsDihydroartemisinin inhibits T cell activation in people living with HIV with incomplete immune reconstitution in vitro
A new study provides insights into the biological mechanisms underlying incomplete immune reconstitution in people with HIV and supports dihydroartemisinin’s potential as a therapeutic agent.